Why vitamin D supplements don't work for everyone

Vitamin D deficiency is one of the most common nutritional problems in the world — including in people who are already taking supplements. Doctors find this puzzling. Patients find it frustrating. The answer is often sitting in the genome.

Most people understand that you need sunlight or a supplement to get vitamin D. What's less well understood is that getting it into your blood is only half the problem. Your cells still have to respond to it — and that response is controlled by a receptor encoded by the VDR gene.

What VDR actually does

VDR stands for vitamin D receptor. When vitamin D — specifically the active form, calcitriol — reaches a cell, it binds to the VDR protein. That binding triggers a cascade: genes involved in calcium absorption, immune regulation, cell growth and dozens of other processes get switched on or modulated. Without a functional VDR, vitamin D in your bloodstream is a key that can't find the lock.

The VDR gene has several well-studied variants. The most clinically relevant for supplementation are BsmI (rs1544410), FokI (rs2228570), TaqI (rs731236) and ApaI (rs7975232). They don't all do the same thing — some affect receptor stability, some affect how efficiently the receptor initiates gene transcription — but together they paint a picture of how well your cells respond to the vitamin D you've got.

Why standard doses can leave you deficient

Most supplement bottles recommend 400–800 IU of vitamin D per day. That dose was set to prevent outright deficiency — rickets and osteomalacia — in the average person. It wasn't designed with genetic variation in mind.

Studies consistently show that people carrying reduced-function VDR variants need significantly higher doses to achieve the same serum 25(OH)D levels as people with fully functional receptors taking the same supplement. Some research puts the difference at two to three times the dose for equivalent effect. This is why a person can supplement diligently for months and still show up at their annual blood test with low vitamin D.

It's not absorption failure. It's receptor sensitivity. Two entirely different problems with different solutions.

GC (VDBP): the gene that controls how much vitamin D reaches your receptor

There's a second gene in the vitamin D pathway that's worth knowing about: GC, which encodes the vitamin D binding protein (VDBP). This protein transports vitamin D through the bloodstream. Some GC variants reduce the binding protein's efficiency, which means less vitamin D reaches the cells even when blood levels look adequate.

This is one of the reasons blood tests for vitamin D (which measure total serum 25(OH)D) can look normal while functional vitamin D activity is lower than expected. The transport system is the bottleneck, not the supply.

What vitamin D actually does — and why this matters

Vitamin D is often described as "the bone vitamin" and left there. That's a significant undersell. The VDR receptor is expressed in almost every tissue in the body — immune cells, heart muscle, brain, gut, skin. Vitamin D influences:

• Calcium absorption — the classic function, still central to bone density
• Immune modulation — VDR activation regulates T-cell differentiation and inflammatory response
• Mood and neurological function — VDR is expressed in the brain; multiple studies link low vitamin D to depressive symptoms
• Cardiovascular health — VDR activation has direct effects on blood pressure regulation via the renin-angiotensin system
• Muscle function — vitamin D insufficiency is associated with muscle weakness and slower recovery

This breadth is why a genetically-driven gap in vitamin D response isn't a minor footnote. The downstream effects spread across multiple systems.

Vitamin D doesn't work alone

Even with a well-functioning VDR, vitamin D needs cofactors to do its job. Magnesium is required to convert vitamin D into its active form — and most people are also deficient in magnesium. Vitamin K2 works alongside vitamin D to direct calcium to bone rather than soft tissue; high-dose D without adequate K2 can contribute to arterial calcification over time.

A complete vitamin D strategy therefore means understanding your VDR status, your GC transport variant, your magnesium intake, and your K2 status — not just picking a dose from a label.

How MyGNLab uses it

VDR and GC are both included in the DNA analysis. Your report identifies your receptor sensitivity profile and your transport variant, and your supplement formula is dosed accordingly — along with the magnesium and K2 that the full pathway requires. If your VDR suggests reduced sensitivity, you get more. Not a generic "high dose", but a calculated amount matched to what the research shows your genotype needs to achieve functional effect.

← Back to the blog